Explore our cutting-edge technologies designed to unlock the complexities of diploid genomes
In diploid organisms, chromosomes are inherited in pairs—one set from each parent. Standard genome sequencing methods typically collapse these homologous chromosome pairs into a single consensus sequence. While this approach provides a general representation of a species' genome, it completely masks the crucial differences between paternal and maternal alleles. Haplotype-resolved phased sequencing solves this limitation by separately assembling the maternal and paternal chromosomes. This level of resolution is essential for understanding genetic variation, allele-specific expression, and the structural variations that underpin complex traits and diseases.
The advent of long-read sequencing technologies, such as Pacific Biosciences (PacBio) HiFi sequencing and Oxford Nanopore Technologies (ONT), has revolutionized the genomic assembly pipeline. By generating reads that span tens of thousands of base pairs, scientists can now bridge highly repetitive regions and accurately assign single nucleotide polymorphisms (SNPs) and structural variants (SVs) to their respective parental chromosomes. When combined with chromosome conformation capture techniques like Hi-C, these long reads allow for chromosome-level, haplotype-resolved assemblies that represent the absolute pinnacle of genomic accuracy.
Italy has emerged as a key hub for genetic research and precision medicine in Southern Europe. The Italian scientific community, supported by academic institutions such as the University of Milan, the University of Padua, and the University of Bologna, has increasingly adopted haplotype-resolved assemblies to drive local innovations. From investigating the rich genetic diversity of the Mediterranean population to protecting endemic agricultural varieties, Italian laboratories are at the forefront of applying phased genome assemblies.
Currently, several domestic and international companies serve the Italian biotech sector. Local genomics companies and contract research organizations (CROs) in cities like Milan, Rome, and Naples offer sequencing services. However, due to the high capital cost of maintaining advanced long-read platforms like the PacBio Sequel IIe or Oxford Nanopore PromethION P48, many Italian research institutes partner with global multi-omics leaders like Biomarker Technologies (BMKGene). These partnerships allow Italian researchers to access high-throughput, certified sequencing lines at competitive prices.
The cost of achieving a high-quality, chromosome-level phased assembly depends on several factors, including genome size, heterozygosity, repeat content, and the specific technology combination utilized. Typically, a hybrid approach combining long reads (PacBio HiFi or Nanopore) with spatial proximity data (Hi-C) is recommended.
Below is a general pricing guide applicable to Italian research institutions and companies. Please note that prices vary based on sample volume, extraction complexity, and bioinformatics depth:
For precise, project-specific quotes tailored to your research budget, please use our inquiry form below to connect with our local European support team.
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5, MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
Waters XEVO G2-XS QTOF
QTRAP 6500+
Biomarker technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services.
Demonstrated excellence and compliance with international genomic standards
We will be in touch within 24 hours.
Inquiry NowAdvanced Sequencing, Epigenetics, and Spatial Biology Services